0001752724-24-068300.txt : 20240326 0001752724-24-068300.hdr.sgml : 20240326 20240326144051 ACCESSION NUMBER: 0001752724-24-068300 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240131 FILED AS OF DATE: 20240326 DATE AS OF CHANGE: 20240326 PERIOD START: 20241031 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SCHWAB CAPITAL TRUST CENTRAL INDEX KEY: 0000904333 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-07704 FILM NUMBER: 24782984 BUSINESS ADDRESS: STREET 1: 211 MAIN STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: 1-415-667-7000 MAIL ADDRESS: STREET 1: 211 MAIN STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94105 0000904333 S000005519 Schwab Health Care Fund C000015021 Schwab Health Care Fund SWHFX NPORT-P 1 primary_doc.xml NPORT-P false 0000904333 XXXXXXXX S000005519 C000015021 SCHWAB CAPITAL TRUST 811-07704 0000904333 549300PEK1H7N1HLC797 211 MAIN STREET SAN FRANCISCO 94105 800-648-5300 Schwab Health Care Fund S000005519 5493000OCKQ3NPNPGA79 2024-10-31 2024-01-31 N 804222770.38 12726223.51 791496546.87 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 2187182.51000000 N Swedish Orphan Biovitrum AB 549300124Y3MQI87PT35 Swedish Orphan Biovitrum AB 000000000 44621.00000000 NS 1252427.97000000 0.158235430710 Long EC CORP SE N 2 N N N DENTSPLY SIRONA Inc 9NHEHR1SOZCYXDO8HO28 DENTSPLY SIRONA Inc 24906P109 74798.00000000 NS USD 2599230.50000000 0.328394420705 Long EC CORP US N 1 N N N Vertex Pharmaceuticals Inc 54930015RAQRRZ5ZGJ91 Vertex Pharmaceuticals Inc 92532F100 56091.00000000 NS USD 24308717.58000000 3.071234824223 Long EC CORP US N 1 N N N Johnson & Johnson 549300G0CFPGEF6X2043 Johnson & Johnson 478160104 191300.00000000 NS USD 30397570.00000000 3.840518334566 Long EC CORP US N 1 N N N UnitedHealth Group Inc 549300GHBMY8T5GXDE41 UnitedHealth Group Inc 91324P102 83440.00000000 NS USD 42699585.60000000 5.394791142027 Long EC CORP US N 1 N N N Cochlear Ltd 5493001OLLWY8KV5UC08 Cochlear Ltd 000000000 24127.00000000 NS 4787977.06000000 0.604927093988 Long EC CORP AU N 2 N N N Prestige Consumer Healthcare Inc N/A Prestige Consumer Healthcare Inc 74112D101 84613.00000000 NS USD 5207084.02000000 0.657878299102 Long EC CORP US N 1 N N N AbbVie Inc FR5LCKFTG8054YNNRU85 AbbVie Inc 00287Y109 194914.00000000 NS USD 32043861.60000000 4.048515653886 Long EC CORP US N 1 N N N Thermo Fisher Scientific Inc HCHV7422L5HDJZCRFL38 Thermo Fisher Scientific Inc 883556102 22414.00000000 NS USD 12080697.72000000 1.526310856032 Long EC CORP US N 1 N N N Agilent Technologies Inc QUIX8Y7A2WP0XRMW7G29 Agilent Technologies Inc 00846U101 88508.00000000 NS USD 11514890.80000000 1.454825146810 Long EC CORP US N 1 N N N BioMarin Pharmaceutical Inc NSLL8ITTRR0J5HEMR848 BioMarin Pharmaceutical Inc 09061G101 85542.00000000 NS USD 7534539.36000000 0.951935847325 Long EC CORP US N 1 N N N Merit Medical Systems Inc 549300OYTY138SP2CE83 Merit Medical Systems Inc 589889104 50493.00000000 NS USD 3953601.90000000 0.499509683982 Long EC CORP US N 1 N N N Getinge AB 5493003PZ4F570G3W735 Getinge AB 000000000 52784.00000000 NS 1128370.28000000 0.142561617541 Long EC CORP SE N 2 N N N DaVita Inc M2XHYMU3TZNEZURC6H66 DaVita Inc 23918K108 8300.00000000 NS USD 897728.00000000 0.113421594010 Long EC CORP US N 1 N N N Bruker Corp LEBZ6VLQ6I8XB1NHVY15 Bruker Corp 116794108 30109.00000000 NS USD 2153094.59000000 0.272028298609 Long EC CORP US N 1 N N N Medtronic PLC 549300GX3ZBSQWUXY261 Medtronic PLC 000000000 267905.00000000 NS USD 23452403.70000000 2.963045611853 Long EC CORP IE N 1 N N N Santen Pharmaceutical Co Ltd 529900TPT3I7C17MIM03 Santen Pharmaceutical Co Ltd 000000000 80000.00000000 NS 808185.75000000 0.102108562974 Long EC CORP JP N 2 N N N Genmab A/S 529900MTJPDPE4MHJ122 Genmab A/S 000000000 5676.00000000 NS 1569538.94000000 0.198300162673 Long EC CORP DK N 2 N N N Roche Holding AG 549300U41AUUVOAAOB37 Roche Holding AG 000000000 56410.00000000 NS 16060849.48000000 2.029174927359 Long EC CORP CH N 2 N N N Zoetis Inc 549300HD9Q1LOC9KLJ48 Zoetis Inc 98978V103 65210.00000000 NS USD 12247090.10000000 1.547333358361 Long EC CORP US N 1 N N N Halozyme Therapeutics Inc 529900242I3SV9AGM753 Halozyme Therapeutics Inc 40637H109 72907.00000000 NS USD 2467901.95000000 0.311801985714 Long EC CORP US N 1 N N N Boston Scientific Corp Y6ZDD9FP4P8JSSJMW954 Boston Scientific Corp 101137107 64706.00000000 NS USD 4093301.56000000 0.517159749614 Long EC CORP US N 1 N N N Zimmer Biomet Holdings Inc 2P2YLDVPES3BXQ1FRB91 Zimmer Biomet Holdings Inc 98956P102 58903.00000000 NS USD 7398216.80000000 0.934712454432 Long EC CORP US N 1 N N N Elevance Health Inc 8MYN82XMYQH89CTMTH67 Elevance Health Inc 036752103 31612.00000000 NS USD 15598625.28000000 1.970776163419 Long EC CORP US N 1 N N N Novo Nordisk A/S 549300DAQ1CVT6CXN342 Novo Nordisk A/S 000000000 356463.00000000 NS 40745283.90000000 5.147878921408 Long EC CORP DK N 2 N N N United Therapeutics Corp 5299005C4HZL4UWROC14 United Therapeutics Corp 91307C102 37155.00000000 NS USD 7980150.90000000 1.008235718975 Long EC CORP US N 1 N N N Addus HomeCare Corp 52990090ZT33AKPDBX62 Addus HomeCare Corp 006739106 8496.00000000 NS USD 735753.60000000 0.092957272259 Long EC CORP US N 1 N N N Align Technology Inc 549300N5YSE0U3LCP840 Align Technology Inc 016255101 7581.00000000 NS USD 2026552.92000000 0.256040652105 Long EC CORP US N 1 N N N Becton Dickinson & Co ICE2EP6D98PQUILVRZ91 Becton Dickinson & Co 075887109 64508.00000000 NS USD 15405155.48000000 1.946332620264 Long EC CORP US N 1 N N N IQVIA Holdings Inc 549300W3R20NM4KQPH86 IQVIA Holdings Inc 46266C105 57440.00000000 NS USD 11960731.20000000 1.511153933305 Long EC CORP US N 1 N N N Veeva Systems Inc 549300YZEXPDB92M2F02 Veeva Systems Inc 922475108 34443.00000000 NS USD 7143822.63000000 0.902571547311 Long EC CORP US N 1 N N N Stryker Corp 5493002F0SC4JTBU5137 Stryker Corp 863667101 50401.00000000 NS USD 16908527.48000000 2.136273057269 Long EC CORP US N 1 N N N Amphastar Pharmaceuticals Inc 54930055TH0ZLSAQMJ38 Amphastar Pharmaceuticals Inc 03209R103 35572.00000000 NS USD 1898121.92000000 0.239814302097 Long EC CORP US N 1 N N N GSK PLC 5493000HZTVUYLO1D793 GSK PLC 000000000 555579.00000000 NS 10988093.28000000 1.388267999835 Long EC CORP GB N 2 N N N Cigna Group/The 549300VIWYMSIGT1U456 Cigna Group/The 125523100 44755.00000000 NS USD 13469017.25000000 1.701715225829 Long EC CORP US N 1 N N N Incyte Corp 549300Z4WN6JVZ3T4680 Incyte Corp 45337C102 78045.00000000 NS USD 4586704.65000000 0.579497746154 Long EC CORP US N 1 N N N AstraZeneca PLC PY6ZZQWO2IZFZC3IOL08 AstraZeneca PLC 000000000 124408.00000000 NS 16493619.46000000 2.083852358576 Long EC CORP GB N 2 N N N Intuitive Surgical Inc 54930052SRG011710797 Intuitive Surgical Inc 46120E602 29296.00000000 NS USD 11080333.12000000 1.399921852321 Long EC CORP US N 1 N N N Amgen Inc 62QBXGPJ34PQ72Z12S66 Amgen Inc 031162100 74383.00000000 NS USD 23375601.58000000 2.953342206284 Long EC CORP US N 1 N N N Medpace Holdings Inc 549300H8TYEUVTW14A54 Medpace Holdings Inc 58506Q109 19082.00000000 NS USD 5563929.56000000 0.702963213421 Long EC CORP US N 1 N N N Ono Pharmaceutical Co Ltd 529900G26L4NG4GFJZ86 Ono Pharmaceutical Co Ltd 000000000 150300.00000000 NS 2709026.27000000 0.342266340985 Long EC CORP JP N 2 N N N Veracyte Inc 529900ESWZRHXOW27Z37 Veracyte Inc 92337F107 39324.00000000 NS USD 983886.48000000 0.124307109600 Long EC CORP US N 1 N N N Abbott Laboratories HQD377W2YR662HK5JX27 Abbott Laboratories 002824100 215669.00000000 NS USD 24402947.35000000 3.083140090314 Long EC CORP US N 1 N N N Blueprint Medicines Corp 5299004CC60O9T5HVM83 Blueprint Medicines Corp 09627Y109 9342.00000000 NS USD 742969.26000000 0.093868919951 Long EC CORP US N 1 N N N Ipsen SA 549300M6SGDPB4Z94P11 Ipsen SA 000000000 56205.00000000 NS 6480386.94000000 0.818751132348 Long EC CORP FR N 2 N N N CSL Ltd 529900ECSECK5ZDQTE14 CSL Ltd 000000000 9100.00000000 NS 1787035.52000000 0.225779319829 Long EC CORP AU N 2 N N N Dexcom Inc 549300YSK3QDSFR5EU59 Dexcom Inc 252131107 23446.00000000 NS USD 2845172.10000000 0.359467405290 Long EC CORP US N 1 N N N Pfizer Inc 765LHXWGK1KXCLTFYQ30 Pfizer Inc 717081103 196570.00000000 NS USD 5323115.60000000 0.672538069944 Long EC CORP US N 1 N N N Hoya Corp 353800X4VR3BHEUCJB42 Hoya Corp 000000000 80400.00000000 NS 10213137.20000000 1.290357771033 Long EC CORP JP N 2 N N N Bio-Techne Corp 54930073RLKQ51TILZ35 Bio-Techne Corp 09073M104 21675.00000000 NS USD 1524186.00000000 0.192570138938 Long EC CORP US N 1 N N N Jazz Pharmaceuticals PLC 635400GAUMJCLEZRRV50 Jazz Pharmaceuticals PLC 000000000 28774.00000000 NS USD 3531145.28000000 0.446135272979 Long EC CORP IE N 1 N N N Edwards Lifesciences Corp YA13X31F3V31L8TMPR58 Edwards Lifesciences Corp 28176E108 12488.00000000 NS USD 979933.36000000 0.123807660800 Long EC CORP US N 1 N N N BioMerieux 549300AK8Y0LBIQ4T071 BioMerieux 000000000 30781.00000000 NS 3312904.57000000 0.418562100251 Long EC CORP FR N 2 N N N Cardinal Health Inc CCU46N3GJMF4OK4N7U60 Cardinal Health Inc 14149Y108 25072.00000000 NS USD 2737611.68000000 0.345877905699 Long EC CORP US N 1 N N N Option Care Health Inc 549300DI3Q5ACSYJRI17 Option Care Health Inc 68404L201 180658.00000000 NS USD 5643755.92000000 0.713048710359 Long EC CORP US N 1 N N N Sanofi SA 549300E9PC51EN656011 Sanofi SA 000000000 53734.00000000 NS 5381220.22000000 0.679879178409 Long EC CORP FR N 2 N N N Neurocrine Biosciences Inc 549300FECER0XBN49756 Neurocrine Biosciences Inc 64125C109 35581.00000000 NS USD 4973156.37000000 0.628323192269 Long EC CORP US N 1 N N N HealthEquity Inc 529900LRJU1RAFQHM467 HealthEquity Inc 42226A107 10785.00000000 NS USD 815130.30000000 0.102985957831 Long EC CORP US N 1 N N N HCA Healthcare Inc 529900PH4ZGUH2MNEU89 HCA Healthcare Inc 40412C101 9558.00000000 NS USD 2914234.20000000 0.368192913983 Long EC CORP US N 1 N N N McKesson Corp 549300WZWOM80UCFSF54 McKesson Corp 58155Q103 39397.00000000 NS USD 19694166.33000000 2.488218856782 Long EC CORP US N 1 N N N Humana Inc 529900YLDW34GJAO4J06 Humana Inc 444859102 3330.00000000 NS USD 1258939.80000000 0.159058154451 Long EC CORP US N 1 N N N ALK-Abello A/S 529900SGCREUZCZ7P020 ALK-Abello A/S 000000000 56307.00000000 NS 908619.24000000 0.114797625282 Long EC CORP DK N 2 N N N Pro Medicus Ltd N/A Pro Medicus Ltd 000000000 69556.00000000 NS 4582280.00000000 0.578938722868 Long EC CORP AU N 2 N N N Lantheus Holdings Inc 5299005HUB5IOJGO7S39 Lantheus Holdings Inc 516544103 31722.00000000 NS USD 1647323.46000000 0.208127687545 Long EC CORP US N 1 N N N Danaher Corp S4BKK9OTCEWQ3YHPFM11 Danaher Corp 235851102 42006.00000000 NS USD 10077659.46000000 1.273241115182 Long EC CORP US N 1 N N N Regeneron Pharmaceuticals Inc 549300RCBFWIRX3HYQ56 Regeneron Pharmaceuticals Inc 75886F107 16449.00000000 NS USD 15507788.22000000 1.959299542281 Long EC CORP US N 1 N N N Shionogi & Co Ltd 35380049VXDTHZI3DY35 Shionogi & Co Ltd 000000000 47800.00000000 NS 2294228.54000000 0.289859576655 Long EC CORP JP N 2 N N N Demant A/S 213800RM6L9LN78BVA56 Demant A/S 000000000 49790.00000000 NS 2255431.22000000 0.284957809218 Long EC CORP DK N 2 N N N ConvaTec Group PLC 213800LS272L4FIDOH92 ConvaTec Group PLC 000000000 239228.00000000 NS 728060.42000000 0.091985293287 Long EC CORP GB N 2 N N N Novartis AG 5493007HIVTX6SY6XD66 Novartis AG 000000000 241817.00000000 NS 25007195.06000000 3.159482521925 Long EC CORP CH N 2 N N N Mettler-Toledo International Inc 5493000BD5GJNUDIUG10 Mettler-Toledo International Inc 592688105 9140.00000000 NS USD 10942316.60000000 1.382484439543 Long EC CORP US N 1 N N N Alkermes PLC N/A Alkermes PLC 000000000 28600.00000000 NS USD 773630.00000000 0.097742687957 Long EC CORP IE N 1 N N N Elanco Animal Health Inc 549300SHPNDCE059M934 Elanco Animal Health Inc 28414H103 428369.00000000 NS USD 6314159.06000000 0.797749413433 Long EC CORP US N 1 N N N Merck & Co Inc 4YV9Y5M8S0BRK1RP0397 Merck & Co Inc 58933Y105 335715.00000000 NS USD 40547657.70000000 5.122910246462 Long EC CORP US N 1 N N N Cooper Cos Inc/The QJKMVPIGLH7530PCUE20 Cooper Cos Inc/The 216648402 5133.00000000 NS USD 1914762.99000000 0.241916783790 Long EC CORP US N 1 N N N STERIS PLC N/A STERIS PLC 000000000 7219.00000000 NS USD 1580600.05000000 0.199697655820 Long EC CORP IE N 1 N N N West Pharmaceutical Services Inc 5493007NKRGM1RJQ1P16 West Pharmaceutical Services Inc 955306105 7983.00000000 NS USD 2977898.49000000 0.376236447496 Long EC CORP US N 1 N N N Eli Lilly & Co FRDRIPF3EKNDJ2CQJL29 Eli Lilly & Co 532457108 96760.00000000 NS USD 62469223.60000000 7.892545311415 Long EC CORP US N 1 N N N IDEXX Laboratories Inc OGMTXK0LUU1HKV2P0J84 IDEXX Laboratories Inc 45168D104 4510.00000000 NS USD 2323010.80000000 0.293496011977 Long EC CORP US N 1 N N N Hologic Inc 549300DYP6F5ZJL0LB74 Hologic Inc 436440101 133177.00000000 NS USD 9913695.88000000 1.252525474584 Long EC CORP US N 1 N N N Bristol-Myers Squibb Co HLYYNH7UQUORYSJQCN42 Bristol-Myers Squibb Co 110122108 26997.00000000 NS USD 1319343.39000000 0.166689721542 Long EC CORP US N 1 N N N Gilead Sciences Inc 549300WTZWR07K8MNV44 Gilead Sciences Inc 375558103 221652.00000000 NS USD 17346485.52000000 2.191605963234 Long EC CORP US N 1 N N N 2024-02-26 SCHWAB CAPITAL TRUST Dana Smith Dana Smith CFO XXXX NPORT-EX 2 NPORT_2M42_77642744_0124.htm EDGAR HTML
Schwab Capital Trust
Schwab Core Equity Fund
Portfolio Holdings as of January 31, 2024 (Unaudited)
The following are the portfolio holdings as of the report date. For more information, please refer to the fund’s semiannual or annual shareholder reports. You can also obtain this information at no cost by calling 1-866-414-6349 or by sending an email request to orders@mysummaryprospectus.com.
SECURITY
NUMBER
OF SHARES
VALUE ($)
COMMON STOCKS 99.7% OF NET ASSETS
 
Capital Goods 5.7%
A O Smith Corp.
189,437
14,702,206
Caterpillar, Inc.
72,830
21,871,577
Fastenal Co.
122,982
8,391,062
General Dynamics Corp.
45,415
12,034,521
Lockheed Martin Corp.
15,326
6,581,138
Parker-Hannifin Corp.
12,337
5,730,536
Rockwell Automation, Inc.
22,358
5,662,834
 
74,973,874
 
Commercial & Professional Services 2.2%
Republic Services, Inc., Class A
80,544
13,782,690
Rollins, Inc.
334,978
14,507,897
 
28,290,587
 
Consumer Discretionary Distribution & Retail 7.6%
Amazon.com, Inc. *
394,176
61,176,115
Home Depot, Inc.
36,635
12,930,690
TJX Cos., Inc.
261,519
24,820,768
 
98,927,573
 
Consumer Services 3.2%
McDonald's Corp.
50,040
14,647,709
Starbucks Corp.
295,544
27,494,458
 
42,142,167
 
Consumer Staples Distribution & Retail 2.0%
Costco Wholesale Corp.
14,143
9,827,688
Walmart, Inc.
99,765
16,486,166
 
26,313,854
 
Energy 4.4%
EOG Resources, Inc.
161,844
18,416,229
Exxon Mobil Corp.
377,413
38,801,830
 
57,218,059
 
Equity Real Estate Investment Trusts (REITs) 1.0%
Public Storage
46,451
13,154,459
 
Financial Services 12.6%
Berkshire Hathaway, Inc., Class B *
55,625
21,345,537
CME Group, Inc.
41,495
8,541,331
Fidelity National Information Services,
Inc.
630,979
39,284,753
Interactive Brokers Group, Inc., Class A
81,929
7,271,199
Morgan Stanley
123,592
10,782,166
SECURITY
NUMBER
OF SHARES
VALUE ($)
PayPal Holdings, Inc. *
563,877
34,593,854
Raymond James Financial, Inc.
60,375
6,652,117
Visa, Inc., Class A
134,673
36,800,744
 
165,271,701
 
Food, Beverage & Tobacco 2.3%
Constellation Brands, Inc., Class A
91,600
22,449,328
Diageo PLC, ADR
54,716
7,897,160
 
30,346,488
 
Health Care Equipment & Services 7.0%
Abbott Laboratories
186,054
21,052,010
Boston Scientific Corp. *
207,454
13,123,540
CVS Health Corp.
200,272
14,894,229
Intuitive Surgical, Inc. *
85,130
32,197,869
UnitedHealth Group, Inc.
19,557
10,008,099
 
91,275,747
 
Household & Personal Products 2.8%
Estee Lauder Cos., Inc., Class A
54,905
7,246,911
Kenvue, Inc.
794,004
16,483,523
L'Oreal SA, Sponsored ADR
141,090
13,488,204
 
37,218,638
 
Insurance 0.5%
Progressive Corp.
38,879
6,930,182
 
Materials 0.7%
Linde PLC
23,368
9,460,067
 
Media & Entertainment 10.0%
Alphabet, Inc., Class A *
615,810
86,274,981
Meta Platforms, Inc., Class A *
114,677
44,740,085
 
131,015,066
 
Pharmaceuticals, Biotechnology & Life Sciences 7.8%
Eli Lilly & Co.
21,268
13,730,834
Johnson & Johnson
215,776
34,286,806
Mettler-Toledo International, Inc. *
5,555
6,650,390
Thermo Fisher Scientific, Inc.
45,948
24,765,053
Zoetis, Inc.
118,905
22,331,548
 
101,764,631
 
Semiconductors & Semiconductor Equipment 7.1%
ASML Holding NV NY Registry Shares
20,750
18,048,765
Broadcom, Inc.
38,165
45,034,700
  1

Schwab Core Equity Fund
Portfolio Holdings (Unaudited) continued
SECURITY
NUMBER
OF SHARES
VALUE ($)
NVIDIA Corp.
20,292
12,485,059
QUALCOMM, Inc.
119,591
17,760,459
 
93,328,983
 
Software & Services 14.1%
Accenture PLC, Class A
37,155
13,519,961
Adobe, Inc. *
21,000
12,973,380
Fortinet, Inc. *
219,005
14,123,633
Microsoft Corp.
328,583
130,638,029
Oracle Corp.
115,283
12,877,111
 
184,132,114
 
Technology Hardware & Equipment 7.2%
Apple, Inc.
511,264
94,277,082
 
Utilities 1.5%
Duke Energy Corp.
209,354
20,062,394
Total Common Stocks
(Cost $815,735,822)
1,306,103,666
SECURITY
NUMBER
OF SHARES
VALUE ($)
SHORT-TERM INVESTMENTS 0.7% OF NET ASSETS
 
Money Market Funds 0.7%
State Street Institutional
U.S. Government Money Market
Fund, Premier Class 5.30% (a)
9,316,199
9,316,199
Total Short-Term Investments
(Cost $9,316,199)
9,316,199
Total Investments in Securities
(Cost $825,052,021)
1,315,419,865
*
Non-income producing security.
(a)
The rate shown is the annualized 7-day yield.
ADR —
American Depositary Receipt

The following is a summary of the inputs used to value the fund’s investments as of January 31, 2024 (see notes to portfolio holdings for additional information):
DESCRIPTION
QUOTED PRICES IN
ACTIVE MARKETS FOR
IDENTICAL ASSETS
(LEVEL 1)
OTHER SIGNIFICANT
OBSERVABLE INPUTS
(LEVEL 2)
SIGNIFICANT
UNOBSERVABLE INPUTS
(LEVEL 3)
TOTAL
Assets
Common Stocks1
$1,306,103,666
$
$
$1,306,103,666
Short-Term Investments1
9,316,199
9,316,199
Total
$1,315,419,865
$—
$—
$1,315,419,865
1
As categorized in the Portfolio Holdings.
2  

Schwab Capital Trust
Schwab Dividend Equity Fund
Portfolio Holdings as of January 31, 2024 (Unaudited)
The following are the portfolio holdings as of the report date. For more information, please refer to the fund’s semiannual or annual shareholder reports. You can also obtain this information at no cost by calling 1-866-414-6349 or by sending an email request to orders@mysummaryprospectus.com.
SECURITY
NUMBER
OF SHARES
VALUE ($)
COMMON STOCKS 99.8% OF NET ASSETS
 
Banks 6.9%
Bank of America Corp.
270,000
9,182,700
JPMorgan Chase & Co.
125,000
21,795,000
Truist Financial Corp.
90,000
3,335,400
 
34,313,100
 
Capital Goods 8.2%
Caterpillar, Inc.
10,000
3,003,100
Fastenal Co.
62,000
4,230,260
General Dynamics Corp.
15,000
3,974,850
Illinois Tool Works, Inc.
18,500
4,826,650
Lockheed Martin Corp.
27,000
11,594,070
Parker-Hannifin Corp.
13,000
6,038,500
RTX Corp.
43,000
3,918,160
Watsco, Inc.
8,000
3,127,840
 
40,713,430
 
Consumer Discretionary Distribution & Retail 5.5%
Genuine Parts Co.
35,000
4,908,050
Home Depot, Inc.
33,500
11,824,160
TJX Cos., Inc.
110,000
10,440,100
 
27,172,310
 
Consumer Services 2.3%
McDonald's Corp.
39,000
11,416,080
 
Consumer Staples Distribution & Retail 2.3%
Walmart, Inc.
70,000
11,567,500
 
Energy 7.5%
Chevron Corp.
100,000
14,743,000
Exxon Mobil Corp.
170,000
17,477,700
Kinder Morgan, Inc.
290,000
4,906,800
 
37,127,500
 
Equity Real Estate Investment Trusts (REITs) 2.9%
Crown Castle, Inc.
48,750
5,277,187
Lamar Advertising Co., Class A
40,000
4,187,200
Public Storage
17,500
4,955,825
 
14,420,212
 
Financial Services 9.4%
BlackRock, Inc.
16,500
12,776,115
Fidelity National Information Services, Inc.
155,000
9,650,300
SECURITY
NUMBER
OF SHARES
VALUE ($)
Morgan Stanley
155,000
13,522,200
Visa, Inc., Class A
38,500
10,520,510
 
46,469,125
 
Food, Beverage & Tobacco 6.9%
Altria Group, Inc.
85,000
3,410,200
Coca-Cola Co.
245,000
14,575,050
Constellation Brands, Inc., Class A
15,000
3,676,200
Philip Morris International, Inc.
138,000
12,537,300
 
34,198,750
 
Health Care Equipment & Services 7.5%
Abbott Laboratories
77,000
8,712,550
CVS Health Corp.
110,000
8,180,700
Medtronic PLC
113,000
9,892,020
UnitedHealth Group, Inc.
20,000
10,234,800
 
37,020,070
 
Household & Personal Products 4.1%
Kenvue, Inc.
280,000
5,812,800
Procter & Gamble Co.
91,000
14,299,740
 
20,112,540
 
Insurance 2.3%
Allstate Corp.
56,000
8,694,000
Progressive Corp.
15,000
2,673,750
 
11,367,750
 
Materials 0.6%
PPG Industries, Inc.
23,000
3,243,920
 
Media & Entertainment 3.1%
Comcast Corp., Class A
275,000
12,798,500
Omnicom Group, Inc.
26,250
2,372,475
 
15,170,975
 
Pharmaceuticals, Biotechnology & Life Sciences 8.0%
AbbVie, Inc.
60,000
9,864,000
Johnson & Johnson
72,310
11,490,059
Merck & Co., Inc.
30,000
3,623,400
Pfizer, Inc.
200,000
5,416,000
Roche Holding AG
20,000
5,694,327
Zoetis, Inc.
18,750
3,521,438
 
39,609,224
 
Semiconductors & Semiconductor Equipment 3.4%
Broadcom, Inc.
14,300
16,874,000
 
  3

Schwab Dividend Equity Fund
Portfolio Holdings (Unaudited) continued
SECURITY
NUMBER
OF SHARES
VALUE ($)
Software & Services 8.4%
Accenture PLC, Class A
36,500
13,281,620
International Business Machines Corp.
60,000
11,019,600
Microsoft Corp.
43,000
17,095,940
 
41,397,160
 
Technology Hardware & Equipment 3.9%
Apple, Inc.
26,000
4,794,400
Cisco Systems, Inc.
287,500
14,426,750
 
19,221,150
 
Telecommunication Services 2.4%
BCE, Inc.
65,000
2,622,750
Verizon Communications, Inc.
225,000
9,528,750
 
12,151,500
 
SECURITY
NUMBER
OF SHARES
VALUE ($)
Transportation 0.9%
United Parcel Service, Inc., Class B
30,000
4,257,000
 
Utilities 3.3%
Duke Energy Corp.
127,500
12,218,325
Eversource Energy
80,000
4,337,600
 
16,555,925
Total Common Stocks
(Cost $392,388,490)
494,379,221
Total Investments in Securities
(Cost $392,388,490)
494,379,221

The following is a summary of the inputs used to value the fund’s investments as of January 31, 2024 (see notes to portfolio holdings for additional information):
DESCRIPTION
QUOTED PRICES IN
ACTIVE MARKETS FOR
IDENTICAL ASSETS
(LEVEL 1)
OTHER SIGNIFICANT
OBSERVABLE INPUTS
(LEVEL 2)
SIGNIFICANT
UNOBSERVABLE INPUTS
(LEVEL 3)
TOTAL
Assets
Common Stocks1
$454,769,997
$
$
$454,769,997
Pharmaceuticals, Biotechnology & Life Sciences
33,914,897
5,694,327
39,609,224
Total
$488,684,894
$5,694,327
$—
$494,379,221
1
As categorized in the Portfolio Holdings.
4  

Schwab Capital Trust
Schwab Large-Cap Growth Fund
Portfolio Holdings as of January 31, 2024 (Unaudited)
The following are the portfolio holdings as of the report date. For more information, please refer to the fund’s semiannual or annual shareholder reports. You can also obtain this information at no cost by calling 1-866-414-6349 or by sending an email request to orders@mysummaryprospectus.com.
SECURITY
NUMBER
OF SHARES
VALUE ($)
COMMON STOCKS 95.4% OF NET ASSETS
 
Automobiles & Components 0.9%
Tesla, Inc. *
17,116
3,205,656
 
Capital Goods 5.5%
Caterpillar, Inc.
11,998
3,603,119
Fastenal Co.
38,044
2,595,742
Illinois Tool Works, Inc.
4,799
1,252,059
Lockheed Martin Corp.
7,652
3,285,845
Parker-Hannifin Corp.
10,673
4,957,609
Quanta Services, Inc.
9,885
1,918,184
Watsco, Inc.
3,371
1,317,994
 
18,930,552
 
Commercial & Professional Services 1.4%
Paychex, Inc.
13,902
1,692,290
Republic Services, Inc., Class A
17,758
3,038,749
 
4,731,039
 
Consumer Discretionary Distribution & Retail 7.6%
Amazon.com, Inc. *
114,359
17,748,517
Home Depot, Inc.
12,073
4,261,286
O'Reilly Automotive, Inc. *
1,888
1,931,519
TJX Cos., Inc.
25,285
2,399,799
 
26,341,121
 
Consumer Durables & Apparel 1.2%
Deckers Outdoor Corp. *
1,850
1,394,400
NIKE, Inc., Class B
28,300
2,873,299
 
4,267,699
 
Consumer Services 3.2%
Airbnb, Inc., Class A *
22,675
3,268,375
McDonald's Corp.
11,088
3,245,679
Starbucks Corp.
48,462
4,508,420
 
11,022,474
 
Consumer Staples Distribution & Retail 1.5%
Costco Wholesale Corp.
7,253
5,039,965
 
Energy 0.5%
EOG Resources, Inc.
14,768
1,680,451
 
SECURITY
NUMBER
OF SHARES
VALUE ($)
Equity Real Estate Investment Trusts (REITs) 0.7%
American Tower Corp.
6,424
1,256,856
Public Storage
4,253
1,204,407
 
2,461,263
 
Financial Services 4.7%
Interactive Brokers Group, Inc., Class A
26,880
2,385,600
Mastercard, Inc., Class A
11,969
5,376,834
MSCI, Inc., Class A
2,815
1,685,115
Visa, Inc., Class A
24,440
6,678,475
 
16,126,024
 
Food, Beverage & Tobacco 2.9%
Celsius Holdings, Inc. *
32,834
1,638,417
Constellation Brands, Inc., Class A
20,689
5,070,460
Philip Morris International, Inc.
34,383
3,123,695
 
9,832,572
 
Health Care Equipment & Services 4.7%
Edwards Lifesciences Corp. *
27,680
2,172,050
IDEXX Laboratories, Inc. *
3,556
1,831,624
Intuitive Surgical, Inc. *
16,517
6,247,060
UnitedHealth Group, Inc.
11,673
5,973,541
 
16,224,275
 
Insurance 1.4%
Arthur J Gallagher & Co.
13,345
3,098,175
Progressive Corp.
10,421
1,857,543
 
4,955,718
 
Media & Entertainment 9.5%
Alphabet, Inc., Class A *
120,240
16,845,624
Meta Platforms, Inc., Class A *
32,346
12,619,468
Netflix, Inc. *
6,145
3,466,456
 
32,931,548
 
Pharmaceuticals, Biotechnology & Life Sciences 6.0%
Eli Lilly & Co.
12,008
7,752,485
Thermo Fisher Scientific, Inc.
12,359
6,661,254
Vertex Pharmaceuticals, Inc. *
5,729
2,482,834
Zoetis, Inc.
20,079
3,771,037
 
20,667,610
 
Semiconductors & Semiconductor Equipment 11.4%
Advanced Micro Devices, Inc. *
21,181
3,551,842
ASML Holding NV NY Registry Shares
5,852
5,090,187
  5

Schwab Large-Cap Growth Fund
Portfolio Holdings (Unaudited) continued
SECURITY
NUMBER
OF SHARES
VALUE ($)
Broadcom, Inc.
9,252
10,917,360
NVIDIA Corp.
32,256
19,846,149
 
39,405,538
 
Software & Services 21.9%
Accenture PLC, Class A
12,870
4,683,136
Adobe, Inc. *
10,158
6,275,409
Gartner, Inc. *
10,548
4,825,077
Intuit, Inc.
4,573
2,887,072
Microsoft Corp.
99,364
39,505,139
Oracle Corp.
34,209
3,821,145
Palo Alto Networks, Inc. *
25,239
8,543,654
ServiceNow, Inc. *
2,645
2,024,483
Synopsys, Inc. *
5,560
2,965,426
 
75,530,541
 
Technology Hardware & Equipment 9.9%
Apple, Inc.
186,176
34,330,854
 
Transportation 0.5%
Uber Technologies, Inc. *
27,145
1,771,754
Total Common Stocks
(Cost $153,758,587)
329,456,654
SECURITY
NUMBER
OF SHARES
VALUE ($)
INVESTMENT COMPANIES 1.4% OF NET ASSETS
 
Equity Funds 1.4%
Invesco S&P 500 Equal Weight ETF
31,462
4,922,545
Total Investment Companies
(Cost $4,945,908)
4,922,545
Total Investments in Securities
(Cost $158,704,495)
334,379,199
 
NUMBER OF
CONTRACTS
NOTIONAL
AMOUNT
($)
CURRENT VALUE/
UNREALIZED
APPRECIATION
($)
FUTURES CONTRACTS
Long
S&P 500 Index, e-mini, expires
03/15/24
20
4,870,500
210,389
*
Non-income producing security.
ETF —
Exchange-Traded Fund

The following is a summary of the inputs used to value the fund’s investments as of January 31, 2024 (see notes to portfolio holdings for additional information):
DESCRIPTION
QUOTED PRICES IN
ACTIVE MARKETS FOR
IDENTICAL ASSETS
(LEVEL 1)
OTHER SIGNIFICANT
OBSERVABLE INPUTS
(LEVEL 2)
SIGNIFICANT
UNOBSERVABLE INPUTS
(LEVEL 3)
TOTAL
Assets
Common Stocks1
$329,456,654
$
$
$329,456,654
Investment Companies1
4,922,545
4,922,545
Futures Contracts2
210,389
210,389
Total
$334,589,588
$—
$—
$334,589,588
1
As categorized in the Portfolio Holdings.
2
Futures contracts are reported at cumulative unrealized appreciation or depreciation.
6  

Schwab Capital Trust
Schwab Small-Cap Equity Fund
Portfolio Holdings as of January 31, 2024 (Unaudited)
The following are the portfolio holdings as of the report date. For more information, please refer to the fund’s semiannual or annual shareholder reports. You can also obtain this information at no cost by calling 1-866-414-6349 or by sending an email request to orders@mysummaryprospectus.com.
SECURITY
NUMBER
OF SHARES
VALUE ($)
COMMON STOCKS 96.0% OF NET ASSETS
 
Automobiles & Components 1.3%
Adient PLC *
19,412
673,790
American Axle & Manufacturing Holdings,
Inc. *
81,681
660,799
Goodyear Tire & Rubber Co. *
36,918
514,637
Modine Manufacturing Co. *
45,326
3,131,573
Patrick Industries, Inc.
15,563
1,562,370
Visteon Corp. *
7,506
865,367
 
7,408,536
 
Banks 9.2%
Associated Banc-Corp.
228,008
4,790,448
BankUnited, Inc.
170,880
4,829,069
Byline Bancorp, Inc.
16,574
361,976
Cathay General Bancorp
13,538
557,359
Customers Bancorp, Inc. *
22,302
1,191,819
CVB Financial Corp.
123,534
2,071,665
Eagle Bancorp, Inc.
33,074
819,904
Enterprise Financial Services Corp.
34,085
1,418,959
First Financial Corp.
5,234
206,324
Great Southern Bancorp, Inc.
37,856
1,971,919
Hancock Whitney Corp.
55,206
2,490,343
HomeTrust Bancshares, Inc.
44,652
1,212,302
International Bancshares Corp.
114,611
6,058,337
Mercantile Bank Corp.
80,576
3,230,292
Metropolitan Bank Holding Corp. *
9,073
439,950
OceanFirst Financial Corp.
168,407
2,901,653
Old Second Bancorp, Inc.
58,767
800,407
Peapack-Gladstone Financial Corp.
45,193
1,246,423
Premier Financial Corp.
66,678
1,392,903
Renasant Corp.
64,594
2,043,108
Republic Bancorp, Inc., Class A
29,304
1,500,072
Trustmark Corp.
52,006
1,403,642
UMB Financial Corp.
34,016
2,806,320
Univest Financial Corp.
74,816
1,589,092
WaFd, Inc.
81,155
2,356,741
WesBanco, Inc.
54,069
1,586,384
Westamerica BanCorp
7,809
372,646
 
51,650,057
 
Capital Goods 12.6%
AAR Corp. *
68,740
4,180,767
AeroVironment, Inc. *
22,644
2,731,772
Allient, Inc.
30,379
846,359
Applied Industrial Technologies, Inc.
8,582
1,514,380
Array Technologies, Inc. *
67,368
891,952
Atkore, Inc. *
45,141
6,885,357
Blue Bird Corp. *
51,010
1,485,921
Boise Cascade Co.
9,083
1,230,383
Ducommun, Inc. *
14,017
691,739
EMCOR Group, Inc.
26,931
6,143,231
SECURITY
NUMBER
OF SHARES
VALUE ($)
EnerSys
42,645
4,075,583
H&E Equipment Services, Inc.
6,562
352,970
Herc Holdings, Inc.
10,232
1,509,118
Hillenbrand, Inc.
7,369
343,174
IES Holdings, Inc. *
20,949
1,716,980
JELD-WEN Holding, Inc. *
110,689
2,058,815
Manitowoc Co., Inc. *
87,783
1,413,306
Moog, Inc., Class A
35,636
4,981,913
Mueller Industries, Inc.
51,380
2,466,240
MYR Group, Inc. *
7,626
1,097,000
NEXTracker, Inc., Class A *
28,116
1,272,811
Preformed Line Products Co.
9,869
1,206,485
REV Group, Inc.
224,595
4,384,095
Shoals Technologies Group, Inc., Class A *
29,734
391,597
Simpson Manufacturing Co., Inc.
8,345
1,510,362
SPX Technologies, Inc. *
9,150
920,856
Sterling Infrastructure, Inc. *
43,665
3,279,242
Tennant Co.
4,077
385,358
Terex Corp.
69,038
4,241,004
Thermon Group Holdings, Inc. *
41,005
1,344,144
Titan International, Inc. *
103,699
1,530,597
UFP Industries, Inc.
8,612
977,031
V2X, Inc. *
10,567
410,951
Wabash National Corp.
42,901
1,085,395
Watts Water Technologies, Inc., Class A
5,805
1,149,448
 
70,706,336
 
Commercial & Professional Services 1.9%
Brink's Co.
13,573
1,097,241
Cimpress PLC *
23,325
1,754,507
Conduent, Inc. *
224,829
809,385
ExlService Holdings, Inc. *
113,469
3,549,310
IBEX Holdings Ltd. *
50,906
917,326
Insperity, Inc.
7,628
874,855
Legalzoom.com, Inc. *
121,114
1,248,685
Mastech Digital, Inc. *
20,057
172,490
TriNet Group, Inc. *
3,542
402,726
 
10,826,525
 
Consumer Discretionary Distribution & Retail 2.9%
Abercrombie & Fitch Co., Class A *
15,894
1,619,599
American Eagle Outfitters, Inc.
148,507
2,943,409
Build-A-Bear Workshop, Inc.
57,306
1,291,104
Caleres, Inc.
21,791
683,584
CarParts.com, Inc. *
319,180
858,594
Dillard's, Inc., Class A
4,168
1,614,141
Group 1 Automotive, Inc.
7,928
2,061,756
Nordstrom, Inc.
102,926
1,868,107
Signet Jewelers Ltd.
13,397
1,332,733
Urban Outfitters, Inc. *
49,018
1,862,684
 
16,135,711
 
  7

Schwab Small-Cap Equity Fund
Portfolio Holdings (Unaudited) continued
SECURITY
NUMBER
OF SHARES
VALUE ($)
Consumer Durables & Apparel 2.0%
Beazer Homes USA, Inc. *
55,612
1,765,681
Crocs, Inc. *
15,879
1,611,401
Dream Finders Homes, Inc., Class A *
14,373
472,440
Green Brick Partners, Inc. *
10,756
561,141
Hovnanian Enterprises, Inc., Class A *
7,753
1,310,024
JAKKS Pacific, Inc. *
5,187
162,664
M/I Homes, Inc. *
10,152
1,293,568
MasterCraft Boat Holdings, Inc. *
68,126
1,319,601
Solo Brands, Inc., Class A *
150,438
419,722
Taylor Morrison Home Corp., Class A *
29,262
1,525,721
Tri Pointe Homes, Inc. *
27,606
953,235
 
11,395,198
 
Consumer Services 3.2%
Bloomin' Brands, Inc.
89,761
2,389,438
Boyd Gaming Corp.
5,491
348,624
Brinker International, Inc. *
79,767
3,413,230
Dave & Buster's Entertainment, Inc. *
6,544
350,300
Duolingo, Inc. *
6,322
1,130,942
Everi Holdings, Inc. *
50,705
527,839
Frontdoor, Inc. *
68,685
2,250,121
Hilton Grand Vacations, Inc. *
17,709
738,465
Inspired Entertainment, Inc. *
82,270
755,239
International Game Technology PLC
19,494
506,064
Light & Wonder, Inc. *
12,679
1,019,138
PlayAGS, Inc. *
173,835
1,514,103
SeaWorld Entertainment, Inc. *
38,997
1,926,452
Stride, Inc. *
16,456
986,537
 
17,856,492
 
Consumer Staples Distribution & Retail 0.8%
Andersons, Inc.
82,220
4,333,816
 
Energy 5.7%
Cactus, Inc., Class A
26,604
1,129,074
California Resources Corp.
7,290
347,587
ChampionX Corp.
22,180
607,954
Chord Energy Corp.
4,511
693,611
Civitas Resources, Inc.
10,337
669,941
CONSOL Energy, Inc.
24,725
2,338,985
CVR Energy, Inc.
72,575
2,447,955
Liberty Energy, Inc., Class A
196,060
4,076,087
Matador Resources Co.
39,715
2,179,956
Murphy Oil Corp.
48,428
1,874,164
Par Pacific Holdings, Inc. *
57,002
2,085,703
Patterson-UTI Energy, Inc.
105,955
1,175,041
PBF Energy, Inc., Class A
41,032
2,072,526
Peabody Energy Corp.
27,391
731,340
Scorpio Tankers, Inc.
10,204
721,423
Select Water Solutions, Inc.
94,748
736,192
SM Energy Co.
53,225
1,973,583
Teekay Corp. *
212,659
1,911,805
Teekay Tankers Ltd., Class A
36,202
2,264,435
U.S. Silica Holdings, Inc. *
138,465
1,484,345
W&T Offshore, Inc.
151,384
460,207
 
31,981,914
 
Equity Real Estate Investment Trusts (REITs) 6.5%
American Assets Trust, Inc.
237,457
5,326,161
Armada Hoffler Properties, Inc.
412,138
4,929,170
Brandywine Realty Trust
118,018
559,405
Broadstone Net Lease, Inc.
134,081
2,154,682
COPT Defense Properties
252,144
5,940,513
SECURITY
NUMBER
OF SHARES
VALUE ($)
EastGroup Properties, Inc.
16,695
2,962,194
Empire State Realty Trust, Inc., Class A
234,155
2,229,156
Innovative Industrial Properties, Inc.
4,603
429,138
Orion Office REIT, Inc.
230,986
1,187,268
Plymouth Industrial REIT, Inc.
39,482
874,131
Ryman Hospitality Properties, Inc.
61,718
6,782,808
Sabra Health Care REIT, Inc.
48,950
652,993
Tanger, Inc.
85,815
2,308,423
 
36,336,042
 
Financial Services 5.9%
AssetMark Financial Holdings, Inc. *
17,932
549,974
Donnelley Financial Solutions, Inc. *
18,902
1,174,192
Enact Holdings, Inc.
71,144
2,026,893
Enova International, Inc. *
45,801
2,492,948
Essent Group Ltd.
36,634
2,020,731
EVERTEC, Inc.
19,151
769,104
Federal Agricultural Mortgage Corp.,
Class C
15,930
2,967,600
Jackson Financial, Inc., Class A
29,413
1,472,709
Merchants Bancorp
47,445
2,075,244
MGIC Investment Corp.
95,345
1,891,645
NMI Holdings, Inc., Class A *
121,007
3,862,544
OneMain Holdings, Inc.
13,692
651,739
Radian Group, Inc.
60,648
1,757,579
Regional Management Corp.
48,070
1,171,947
StepStone Group, Inc., Class A
25,213
843,375
Stifel Financial Corp.
18,983
1,384,810
StoneCo Ltd., Class A *
63,084
1,084,414
StoneX Group, Inc. *
30,757
2,022,273
Virtus Investment Partners, Inc.
12,939
3,055,027
 
33,274,748
 
Food, Beverage & Tobacco 2.1%
Cal-Maine Foods, Inc.
16,422
910,107
Coca-Cola Consolidated, Inc.
8,051
6,935,051
National Beverage Corp. *
22,612
1,045,579
Primo Water Corp.
200,893
2,929,020
 
11,819,757
 
Health Care Equipment & Services 3.4%
AirSculpt Technologies, Inc. *(a)
44,104
320,195
Cerus Corp. *
270,093
488,868
Haemonetics Corp. *
18,775
1,435,537
Health Catalyst, Inc. *
82,185
802,947
HealthEquity, Inc. *
18,515
1,399,364
Hims & Hers Health, Inc. *
189,621
1,626,948
Lantheus Holdings, Inc. *
53,601
2,783,500
Merit Medical Systems, Inc. *
43,245
3,386,083
OmniAb, Inc., Class A *(b)
5,508
0
OmniAb, Inc., Class B *(b)
5,508
0
Option Care Health, Inc. *
25,933
810,147
OraSure Technologies, Inc. *
150,626
1,110,114
Tenet Healthcare Corp. *
8,781
726,540
UFP Technologies, Inc. *
2,246
378,473
Utah Medical Products, Inc.
4,981
394,545
Veradigm, Inc. *
86,267
787,618
Zimvie, Inc. *
97,895
1,711,205
Zynex, Inc. *(a)
65,072
770,452
 
18,932,536
 
8  

Schwab Small-Cap Equity Fund
Portfolio Holdings (Unaudited) continued
SECURITY
NUMBER
OF SHARES
VALUE ($)
Household & Personal Products 0.5%
elf Beauty, Inc. *
10,309
1,644,595
Medifast, Inc.
13,522
738,977
Nature's Sunshine Products, Inc. *
37,813
658,324
 
3,041,896
 
Insurance 1.2%
CNO Financial Group, Inc.
132,276
3,595,262
Employers Holdings, Inc.
21,853
911,707
Genworth Financial, Inc., Class A *
272,283
1,679,986
Investors Title Co.
1,858
310,750
 
6,497,705
 
Materials 4.3%
Alpha Metallurgical Resources, Inc.
2,951
1,178,157
Arch Resources, Inc.
3,578
633,163
Avient Corp.
65,501
2,371,791
Cabot Corp.
12,426
895,915
Carpenter Technology Corp.
21,295
1,311,559
Commercial Metals Co.
19,790
1,033,434
Constellium SE, Class A *
220,404
4,132,575
Ecovyst, Inc. *
187,295
1,734,352
Mativ Holdings, Inc.
24,167
290,729
O-I Glass, Inc. *
56,088
816,641
Orion SA
118,416
2,652,518
Pactiv Evergreen, Inc.
18,849
275,195
Quaker Chemical Corp.
16,828
3,196,310
Ryerson Holding Corp.
30,061
1,031,694
SunCoke Energy, Inc.
216,983
2,224,076
 
23,778,109
 
Media & Entertainment 2.4%
AMC Networks, Inc., Class A *
134,372
2,430,790
Cars.com, Inc. *
33,273
579,948
Entravision Communications Corp., Class A
227,618
917,301
EW Scripps Co., Class A *
43,160
343,985
Gaia, Inc., Class A *
44,500
129,050
Gray Television, Inc.
138,864
1,326,151
IMAX Corp. *
54,112
755,945
Lions Gate Entertainment Corp., Class A *
119,163
1,242,870
Yelp, Inc., Class A *
113,319
4,955,440
Ziff Davis, Inc. *
8,866
597,568
 
13,279,048
 
Pharmaceuticals, Biotechnology & Life Sciences 12.7%
2seventy bio, Inc. *
197,336
1,014,307
ACADIA Pharmaceuticals, Inc. *
130,149
3,372,161
Agios Pharmaceuticals, Inc. *
25,200
570,024
Alector, Inc. *
72,578
432,565
Alkermes PLC *
136,415
3,690,026
Amicus Therapeutics, Inc. *
152,254
1,892,517
Amneal Pharmaceuticals, Inc. *
348,137
1,862,533
Amphastar Pharmaceuticals, Inc. *
32,714
1,745,619
Amylyx Pharmaceuticals, Inc. *
53,933
862,928
ANI Pharmaceuticals, Inc. *
44,330
2,474,501
Anika Therapeutics, Inc. *
24,888
585,366
Arcus Biosciences, Inc. *
37,827
572,701
Arrowhead Pharmaceuticals, Inc. *
23,361
749,888
Arvinas, Inc. *
51,754
2,147,791
Aurinia Pharmaceuticals, Inc. *
173,739
1,309,992
Beam Therapeutics, Inc. *
12,397
302,487
BioCryst Pharmaceuticals, Inc. *
116,784
618,955
Bridgebio Pharma, Inc. *
78,133
2,679,180
CareDx, Inc. *
92,448
791,355
SECURITY
NUMBER
OF SHARES
VALUE ($)
Caribou Biosciences, Inc. *
164,797
1,010,206
Catalyst Pharmaceuticals, Inc. *
131,521
1,893,902
Collegium Pharmaceutical, Inc. *
32,695
1,077,627
Deciphera Pharmaceuticals, Inc. *
89,616
1,283,301
Denali Therapeutics, Inc. *
65,562
1,049,648
Editas Medicine, Inc. *
128,266
901,710
Fate Therapeutics, Inc. *
331,124
2,039,724
Halozyme Therapeutics, Inc. *
49,316
1,669,347
Harmony Biosciences Holdings, Inc. *
53,515
1,687,863
Harvard Bioscience, Inc. *
126,539
556,772
Intellia Therapeutics, Inc. *
16,605
395,531
Ironwood Pharmaceuticals, Inc., Class A *
205,940
2,922,289
Kiniksa Pharmaceuticals Ltd., Class A *
48,448
854,138
Ligand Pharmaceuticals, Inc. *
28,305
2,069,095
MacroGenics, Inc. *
178,739
2,555,968
Medpace Holdings, Inc. *
19,555
5,701,847
MiMedx Group, Inc. *
236,778
1,832,662
Morphic Holding, Inc. *
9,921
314,396
Mural Oncology PLC *
11,720
51,451
Myriad Genetics, Inc. *
18,320
391,865
Nurix Therapeutics, Inc. *
268,046
2,117,563
Organogenesis Holdings, Inc., Class A *
265,465
876,034
Phibro Animal Health Corp., Class A
79,718
861,752
Prestige Consumer Healthcare, Inc. *
10,201
627,769
PTC Therapeutics, Inc. *
27,076
706,413
Quanterix Corp. *
37,022
817,816
Relay Therapeutics, Inc. *
162,618
1,504,216
Rigel Pharmaceuticals, Inc. *
286,774
335,526
TG Therapeutics, Inc. *
43,238
702,185
Vanda Pharmaceuticals, Inc. *
196,999
709,196
Veracyte, Inc. *
97,313
2,434,771
Vericel Corp. *
19,832
852,379
Xencor, Inc. *
37,121
694,163
 
71,174,021
 
Real Estate Management & Development 0.4%
Cushman & Wakefield PLC *
190,056
1,999,389
RMR Group, Inc., Class A
12,431
324,325
 
2,323,714
 
Semiconductors & Semiconductor Equipment 2.7%
Ambarella, Inc. *
5,097
267,898
Amkor Technology, Inc.
78,392
2,481,891
Axcelis Technologies, Inc. *
34,362
4,468,778
Diodes, Inc. *
18,066
1,216,203
Lattice Semiconductor Corp. *
64,917
3,950,849
Photronics, Inc. *
60,931
1,780,404
Synaptics, Inc. *
8,159
871,463
 
15,037,486
 
Software & Services 7.0%
8x8, Inc. *
315,131
1,058,840
Agilysys, Inc. *
4,228
353,926
Alarm.com Holdings, Inc. *
10,732
652,720
Appfolio, Inc., Class A *
21,632
4,743,032
Asana, Inc., Class A *
65,921
1,148,344
BlackLine, Inc. *
35,649
2,091,883
Box, Inc., Class A *
30,222
785,168
CommVault Systems, Inc. *
16,288
1,493,284
Domo, Inc., Class B *
74,301
807,652
eGain Corp. *
188,200
1,411,500
Everbridge, Inc. *
54,978
1,229,308
Hackett Group, Inc.
64,409
1,489,136
PagerDuty, Inc. *
107,748
2,551,473
Q2 Holdings, Inc. *
72,443
3,082,450
Qualys, Inc. *
20,748
3,924,899
  9

Schwab Small-Cap Equity Fund
Portfolio Holdings (Unaudited) continued
SECURITY
NUMBER
OF SHARES
VALUE ($)
Rimini Street, Inc. *
247,510
811,833
Sprinklr, Inc., Class A *
49,359
616,000
Sprout Social, Inc., Class A *
18,153
1,113,323
Squarespace, Inc., Class A *
27,723
859,413
Tenable Holdings, Inc. *
25,061
1,180,373
Unisys Corp. *
266,506
1,796,250
Weave Communications, Inc. *
115,634
1,450,050
Xperi, Inc. *
72,251
771,641
Yext, Inc. *
285,334
1,692,031
Zeta Global Holdings Corp., Class A *
92,943
899,688
Zuora, Inc., Class A *
117,441
1,073,411
 
39,087,628
 
Technology Hardware & Equipment 4.7%
Arlo Technologies, Inc. *
179,986
1,598,276
Bel Fuse, Inc., Class B
20,150
1,347,229
Belden, Inc.
31,827
2,360,927
Calix, Inc. *
7,357
244,105
CommScope Holding Co., Inc. *
256,955
596,136
Daktronics, Inc. *
80,175
607,726
ePlus, Inc. *
5,999
453,164
Extreme Networks, Inc. *
275,134
3,717,060
Fabrinet *
16,503
3,523,556
Itron, Inc. *
10,343
746,144
OSI Systems, Inc. *
15,389
1,970,254
Sanmina Corp. *
8,821
527,672
Super Micro Computer, Inc. *
12,392
6,562,927
Xerox Holdings Corp.
110,771
2,044,833
 
26,300,009
 
Telecommunication Services 0.6%
Iridium Communications, Inc.
19,928
722,589
Liberty Latin America Ltd., Class A *
333,190
2,345,658
Ooma, Inc. *
15,394
166,563
 
3,234,810
 
Transportation 0.7%
ArcBest Corp.
7,337
874,057
Forward Air Corp.
15,666
694,474
Hub Group, Inc., Class A *
18,915
856,471
Matson, Inc.
7,717
864,535
Radiant Logistics, Inc. *
69,136
424,495
 
3,714,032
 
SECURITY
NUMBER
OF SHARES
VALUE ($)
Utilities 1.3%
Chesapeake Utilities Corp.
9,587
970,971
Clearway Energy, Inc., Class A
124,197
2,789,465
Genie Energy Ltd., Class B
989
18,405
Otter Tail Corp.
34,724
3,139,744
Via Renewables, Inc., Class A
21,017
222,991
 
7,141,576
Total Common Stocks
(Cost $461,635,343)
537,267,702
 
 
 
SHORT-TERM INVESTMENTS 0.2% OF NET ASSETS
 
Money Market Funds 0.2%
State Street Institutional U.S. Government
Money Market Fund, Premier Class
5.30% (c)(d)
1,026,056
1,026,056
Total Short-Term Investments
(Cost $1,026,056)
1,026,056
Total Investments in Securities
(Cost $462,661,399)
538,293,758
 
NUMBER OF
CONTRACTS
NOTIONAL
AMOUNT
($)
CURRENT VALUE/
UNREALIZED
APPRECIATION
($)
FUTURES CONTRACTS
Long
Russell 2000 Index, e-mini,
expires 03/15/24
215
21,025,925
175,548
*
Non-income producing security.
(a)
All or a portion of this security is on loan. Securities on loan were valued at
$994,560.
(b)
Fair valued using significant unobservable inputs (see notes to portfolio
holdings for additional information).
(c)
The rate shown is the annualized 7-day yield.
(d)
Security purchased with cash collateral received for securities on loan.
REIT —
Real Estate Investment Trust

10  

Schwab Small-Cap Equity Fund
Portfolio Holdings (Unaudited) continued
The following is a summary of the inputs used to value the fund’s investments as of January 31, 2024 (see notes to portfolio holdings for additional information):
DESCRIPTION
QUOTED PRICES IN
ACTIVE MARKETS FOR
IDENTICAL ASSETS
(LEVEL 1)
OTHER SIGNIFICANT
OBSERVABLE INPUTS
(LEVEL 2)
SIGNIFICANT
UNOBSERVABLE INPUTS
(LEVEL 3)
TOTAL
Assets
Common Stocks1
$518,335,166
$
$
$518,335,166
Health Care Equipment & Services
18,932,536
0
*
18,932,536
Short-Term Investments1
1,026,056
1,026,056
Futures Contracts2
175,548
175,548
Total
$538,469,306
$—
$0
$538,469,306
*
Level 3 amount shown includes securities determined to have no value at January 31, 2024.
1
As categorized in the Portfolio Holdings.
2
Futures contracts are reported at cumulative unrealized appreciation or depreciation.
  11

Schwab Capital Trust
Schwab Health Care Fund
Portfolio Holdings as of January 31, 2024 (Unaudited)
The following are the portfolio holdings as of the report date. For more information, please refer to the fund’s semiannual or annual shareholder reports. You can also obtain this information at no cost by calling 1-866-414-6349 or by sending an email request to orders@mysummaryprospectus.com.
SECURITY
NUMBER
OF SHARES
VALUE ($)
COMMON STOCKS 99.7% OF NET ASSETS
 
Australia 1.4%
Cochlear Ltd.
24,127
4,787,977
CSL Ltd.
9,100
1,787,036
Pro Medicus Ltd.
69,556
4,582,280
 
11,157,293
 
Denmark 5.8%
ALK-Abello AS *
56,307
908,619
Demant AS *
49,790
2,255,431
Genmab AS *
7,092
1,961,094
Novo Nordisk AS, Class B
356,463
40,745,284
 
45,870,428
 
France 1.7%
BioMerieux
34,382
3,700,474
EssilorLuxottica SA
6,013
1,178,386
Ipsen SA
56,205
6,480,387
Sanofi SA
22,205
2,223,731
 
13,582,978
 
Germany 0.1%
Carl Zeiss Meditec AG, Bearer Shares
10,896
1,148,566
 
Ireland 3.0%
Medtronic PLC
267,905
23,452,404
 
Japan 2.8%
Hoya Corp.
93,000
11,813,703
Olympus Corp.
81,000
1,199,097
Ono Pharmaceutical Co. Ltd.
150,300
2,709,026
Santen Pharmaceutical Co. Ltd.
158,000
1,596,167
Shionogi & Co. Ltd.
84,800
4,070,096
Terumo Corp.
25,000
846,299
 
22,234,388
 
Sweden 0.3%
Getinge AB, B Shares
52,784
1,128,370
Swedish Orphan Biovitrum AB *
44,621
1,252,428
 
2,380,798
 
Switzerland 5.2%
Novartis AG
241,817
25,007,195
Roche Holding AG
56,410
16,060,849
 
41,068,044
 
SECURITY
NUMBER
OF SHARES
VALUE ($)
United Kingdom 3.1%
AstraZeneca PLC
124,408
16,493,620
GSK PLC
393,310
7,778,780
 
24,272,400
 
United States 76.3%
Abbott Laboratories
215,669
24,402,947
AbbVie, Inc.
194,914
32,043,862
Addus HomeCare Corp. *
8,496
735,754
Agilent Technologies, Inc.
88,508
11,514,891
Align Technology, Inc. *
7,581
2,026,553
Alkermes PLC *
28,600
773,630
Amgen, Inc.
74,383
23,375,602
Amphastar Pharmaceuticals, Inc. *
35,572
1,898,122
Becton Dickinson & Co.
64,508
15,405,155
BioMarin Pharmaceutical, Inc. *
85,542
7,534,539
Bio-Techne Corp.
21,675
1,524,186
Blueprint Medicines Corp. *
9,342
742,969
Boston Scientific Corp. *
64,706
4,093,302
Bristol-Myers Squibb Co.
26,997
1,319,343
Bruker Corp.
30,109
2,153,095
Cardinal Health, Inc.
25,072
2,737,612
Cigna Group
44,755
13,469,017
Cooper Cos., Inc.
5,133
1,914,763
Danaher Corp.
42,006
10,077,659
DaVita, Inc. *
8,300
897,728
DENTSPLY SIRONA, Inc.
74,798
2,599,230
Dexcom, Inc. *
23,446
2,845,172
Edwards Lifesciences Corp. *
12,488
979,933
Elanco Animal Health, Inc. *
428,369
6,314,159
Elevance Health, Inc.
31,612
15,598,625
Eli Lilly & Co.
96,760
62,469,224
Gilead Sciences, Inc.
221,652
17,346,486
Halozyme Therapeutics, Inc. *
72,907
2,467,902
HCA Healthcare, Inc.
9,558
2,914,234
HealthEquity, Inc. *
10,785
815,130
Hologic, Inc. *
133,177
9,913,696
Humana, Inc.
3,330
1,258,940
IDEXX Laboratories, Inc. *
4,510
2,323,011
Incyte Corp. *
78,045
4,586,705
Intuitive Surgical, Inc. *
29,296
11,080,333
IQVIA Holdings, Inc. *
57,440
11,960,731
Jazz Pharmaceuticals PLC *
28,774
3,531,145
Johnson & Johnson
191,300
30,397,570
Lantheus Holdings, Inc. *
31,722
1,647,323
McKesson Corp.
39,397
19,694,166
Medpace Holdings, Inc. *
19,082
5,563,930
Merck & Co., Inc.
335,715
40,547,658
Merit Medical Systems, Inc. *
50,493
3,953,602
Mettler-Toledo International, Inc. *
9,140
10,942,317
Neurocrine Biosciences, Inc. *
35,581
4,973,156
Option Care Health, Inc. *
180,658
5,643,756
Pfizer, Inc.
196,570
5,323,116
Prestige Consumer Healthcare, Inc. *
84,613
5,207,084
12  

Schwab Health Care Fund
Portfolio Holdings (Unaudited) continued
SECURITY
NUMBER
OF SHARES
VALUE ($)
Regeneron Pharmaceuticals, Inc. *
16,449
15,507,788
STERIS PLC
7,219
1,580,600
Stryker Corp.
50,401
16,908,527
Thermo Fisher Scientific, Inc.
22,414
12,080,698
United Therapeutics Corp. *
37,155
7,980,151
UnitedHealth Group, Inc.
83,440
42,699,586
Veeva Systems, Inc., Class A *
34,443
7,143,823
Veracyte, Inc. *
39,324
983,886
Vertex Pharmaceuticals, Inc. *
56,091
24,308,718
West Pharmaceutical Services, Inc.
7,983
2,977,898
Zimmer Biomet Holdings, Inc.
58,903
7,398,217
Zoetis, Inc.
65,210
12,247,090
 
603,356,045
Total Common Stocks
(Cost $494,919,691)
788,523,344
Total Investments in Securities
(Cost $494,919,691)
788,523,344
*
Non-income producing security.

The following is a summary of the inputs used to value the fund’s investments as of January 31, 2024 (see notes to portfolio holdings for additional information):
DESCRIPTION
QUOTED PRICES IN
ACTIVE MARKETS FOR
IDENTICAL ASSETS
(LEVEL 1)
OTHER SIGNIFICANT
OBSERVABLE INPUTS
(LEVEL 2)
SIGNIFICANT
UNOBSERVABLE INPUTS
(LEVEL 3)
TOTAL
Assets
Common Stocks1
$626,808,449
$
$
$626,808,449
Australia
11,157,293
11,157,293
Denmark
45,870,428
45,870,428
France
13,582,978
13,582,978
Germany
1,148,566
1,148,566
Japan
22,234,388
22,234,388
Sweden
2,380,798
2,380,798
Switzerland
41,068,044
41,068,044
United Kingdom
24,272,400
24,272,400
Total
$626,808,449
$161,714,895
$—
$788,523,344
1
As categorized in the Portfolio Holdings.
  13

Schwab Capital Trust
Schwab International Core Equity Fund
Portfolio Holdings as of January 31, 2024 (Unaudited)
The following are the portfolio holdings as of the report date. For more information, please refer to the fund’s semiannual or annual shareholder reports. You can also obtain this information at no cost by calling 1-866-414-6349 or by sending an email request to orders@mysummaryprospectus.com.
SECURITY
NUMBER
OF SHARES
VALUE ($)
COMMON STOCKS 100.3% OF NET ASSETS
 
Australia 6.3%
ANZ Group Holdings Ltd.
206,416
3,642,082
Aristocrat Leisure Ltd.
153,174
4,416,100
BHP Group Ltd.
267,183
8,174,199
BlueScope Steel Ltd.
41,000
626,001
Commonwealth Bank of Australia
40,263
3,070,231
Fortescue Ltd.
321,838
6,220,082
JB Hi-Fi Ltd.
15,200
565,477
Macquarie Group Ltd.
23,114
2,852,023
National Australia Bank Ltd.
108,648
2,291,429
Qantas Airways Ltd. *
385,482
1,389,802
Technology One Ltd.
205,762
2,102,308
 
35,349,734
 
Austria 1.0%
Erste Group Bank AG
23,066
993,646
Wienerberger AG
131,042
4,440,747
 
5,434,393
 
Belgium 0.1%
Colruyt Group NV
16,581
757,553
 
Brazil 0.2%
Vale SA
94,900
1,297,922
 
Canada 2.0%
CGI, Inc. *
66,709
7,470,495
Imperial Oil Ltd.
51,700
2,982,138
Suncor Energy, Inc.
27,900
923,878
 
11,376,511
 
China 0.7%
COSCO SHIPPING Holdings Co. Ltd.,
H Shares
1,977,500
2,077,615
Tencent Holdings Ltd.
57,500
1,995,900
 
4,073,515
 
Denmark 5.2%
Novo Nordisk AS, Class B
221,307
25,296,361
Pandora AS
19,126
2,794,632
Rockwool AS, B Shares
4,210
1,147,759
 
29,238,752
 
France 12.1%
BNP Paribas SA
35,323
2,373,146
Cie de Saint-Gobain SA
127,447
9,011,335
SECURITY
NUMBER
OF SHARES
VALUE ($)
Cie Generale des Etablissements Michelin
SCA
227,505
7,553,771
Eiffage SA
55,801
5,838,468
Engie SA
351,374
5,612,311
Hermes International SCA
1,695
3,575,872
Ipsen SA
57,701
6,652,874
Klepierre SA
41,000
1,061,518
L'Oreal SA
25,318
12,116,031
LVMH Moet Hennessy Louis Vuitton SE
5,204
4,330,033
Sanofi SA
22,454
2,248,668
Schneider Electric SE
14,200
2,789,590
Societe Generale SA
127,605
3,280,089
TotalEnergies SE
28,969
1,879,381
 
68,323,087
 
Germany 9.1%
Allianz SE
17,113
4,572,182
Bayerische Motoren Werke AG
22,220
2,312,060
Deutsche Telekom AG
209,837
5,151,039
Fresenius SE & Co. KGaA
38,820
1,089,787
Heidelberg Materials AG
107,711
9,946,512
Infineon Technologies AG
85,787
3,127,530
Mercedes-Benz Group AG
57,599
3,888,668
SAP SE
55,888
9,682,405
Siemens AG
52,477
9,394,634
Vonovia SE
72,567
2,260,633
 
51,425,450
 
Hong Kong 0.8%
China Medical System Holdings Ltd.
366,000
523,026
NetEase, Inc.
57,000
1,107,972
PetroChina Co. Ltd., H Shares
3,942,000
2,851,507
 
4,482,505
 
Israel 0.3%
Check Point Software Technologies Ltd. *
11,600
1,843,588
 
Italy 4.0%
A2A SpA
335,375
664,936
Assicurazioni Generali SpA
61,244
1,366,165
Enel SpA
899,393
6,136,896
Stellantis NV
335,309
7,385,732
UniCredit SpA
102,000
2,987,790
Unipol Gruppo SpA
682,764
4,239,696
 
22,781,215
 
Japan 22.6%
Dai-ichi Life Holdings, Inc.
69,000
1,513,361
Daiwa House Industry Co. Ltd.
36,000
1,113,190
Denso Corp.
148,000
2,324,791
Disco Corp.
7,300
1,969,824
14  

Schwab International Core Equity Fund
Portfolio Holdings (Unaudited) continued
SECURITY
NUMBER
OF SHARES
VALUE ($)
Fast Retailing Co. Ltd.
10,400
2,776,558
Fujikura Ltd.
327,800
2,694,683
Hikari Tsushin, Inc.
3,600
627,299
Hitachi Ltd.
101,000
7,933,585
Honda Motor Co. Ltd.
297,000
3,319,884
Hoya Corp.
65,803
8,358,894
Inpex Corp.
298,100
4,051,911
Japan Exchange Group, Inc.
236,700
5,238,574
Japan Post Insurance Co. Ltd.
49,100
919,244
Japan Tobacco, Inc.
157,782
4,158,721
Lawson, Inc.
158,500
9,072,238
Makita Corp.
45,100
1,213,866
Mitsubishi Corp.
111,900
1,928,590
Mitsui Fudosan Co. Ltd.
77,000
1,932,990
Nexon Co. Ltd.
105,400
1,682,081
Nippon Building Fund, Inc.
325
1,314,985
Nippon Yusen KK
50,000
1,723,043
Nomura Holdings, Inc.
520,000
2,800,796
Obic Co. Ltd.
4,370
671,274
Ono Pharmaceutical Co. Ltd.
208,100
3,750,821
Oracle Corp.
38,500
3,034,152
ORIX Corp.
345,300
6,667,489
Panasonic Holdings Corp.
274,900
2,589,222
Persol Holdings Co. Ltd.
473,200
752,251
Recruit Holdings Co. Ltd.
155,400
6,138,100
Sega Sammy Holdings, Inc.
224,400
3,302,630
Sekisui House Ltd. (a)
102,000
2,302,568
Shimamura Co. Ltd.
10,600
1,162,910
Sompo Holdings, Inc.
29,200
1,514,062
Sony Group Corp.
37,800
3,706,982
Sumitomo Mitsui Financial Group, Inc.
156,100
8,119,284
Tokio Marine Holdings, Inc.
59,000
1,555,678
Tokyo Electron Ltd.
25,400
4,713,539
Tokyo Gas Co. Ltd.
97,000
2,228,271
Toyo Suisan Kaisha Ltd.
43,000
2,239,073
Toyota Motor Corp.
237,000
4,732,372
 
127,849,786
 
Netherlands 5.8%
ABN AMRO Bank NV, GDR
133,499
1,964,756
ASML Holding NV
24,119
20,925,352
Koninklijke Ahold Delhaize NV
177,725
4,998,187
Wolters Kluwer NV
32,932
4,854,738
 
32,743,033
 
Norway 0.4%
Equinor ASA
68,221
1,952,286
Norsk Hydro ASA
85,717
502,345
 
2,454,631
 
Republic of Korea 1.4%
Doosan Bobcat, Inc.
72,614
2,765,433
Kia Corp. *
62,597
4,808,142
 
7,573,575
 
Singapore 0.8%
Jardine Cycle & Carriage Ltd.
104,500
2,016,435
Jardine Matheson Holdings Ltd.
63,600
2,553,801
 
4,570,236
 
Spain 1.7%
Banco Bilbao Vizcaya Argentaria SA
249,581
2,335,938
Banco Santander SA
1,078,329
4,333,868
SECURITY
NUMBER
OF SHARES
VALUE ($)
Endesa SA
105,189
2,083,999
Industria de Diseno Textil SA
24,116
1,031,137
 
9,784,942
 
Sweden 1.5%
Assa Abloy AB, B Shares
26,900
737,752
Atlas Copco AB, A Shares
237,205
3,785,653
Investor AB, B Shares
67,688
1,593,698
Nordea Bank Abp
144,421
1,779,828
SSAB AB, A Shares
85,965
668,791
 
8,565,722
 
Switzerland 8.8%
ABB Ltd.
57,000
2,411,773
Holcim AG *
119,580
9,133,380
Logitech International SA
42,871
3,594,016
Nestle SA
75,127
8,560,761
Novartis AG
161,239
16,674,324
Partners Group Holding AG
706
952,518
Roche Holding AG
17,766
5,058,271
UBS Group AG
103,535
3,099,072
 
49,484,115
 
Taiwan 1.3%
MediaTek, Inc.
89,000
2,746,328
Taiwan Semiconductor Manufacturing Co.
Ltd.
237,000
4,744,383
 
7,490,711
 
United Kingdom 14.2%
AstraZeneca PLC
17,265
2,288,939
BAE Systems PLC
367,128
5,468,909
Centrica PLC
1,578,971
2,763,277
CRH PLC
58,324
4,137,599
Games Workshop Group PLC
28,587
3,588,414
Glencore PLC
788,625
4,172,582
GSK PLC
336,163
6,648,542
Hikma Pharmaceuticals PLC
71,900
1,754,148
Howden Joinery Group PLC
249,394
2,525,584
HSBC Holdings PLC
962,192
7,512,509
Imperial Brands PLC
180,648
4,336,478
Investec PLC
401,314
2,612,761
Legal & General Group PLC
830,297
2,670,602
Man Group PLC
794,733
2,387,989
NatWest Group PLC
597,172
1,685,302
Next PLC
58,557
6,251,341
RELX PLC
72,000
2,971,732
Rio Tinto PLC
38,893
2,692,151
Shell PLC
299,996
9,300,568
Tesco PLC
762,547
2,763,180
Unilever PLC
28,498
1,386,719
 
79,919,326
Total Common Stocks
(Cost $459,802,076)
566,820,302
  15

Schwab International Core Equity Fund
Portfolio Holdings (Unaudited) continued
SECURITY
NUMBER
OF SHARES
VALUE ($)
SHORT-TERM INVESTMENTS 0.7% OF NET ASSETS
 
Money Market Funds 0.7%
State Street Institutional U.S. Government
Money Market Fund, Premier Class
5.30% (b)
1,619,701
1,619,701
State Street Institutional U.S. Government
Money Market Fund, Premier Class
5.30% (b)(c)
2,284,800
2,284,800
 
3,904,501
Total Short-Term Investments
(Cost $3,904,501)
3,904,501
Total Investments in Securities
(Cost $463,706,577)
570,724,803
*
Non-income producing security.
(a)
All or a portion of this security is on loan. Securities on loan were valued at
$2,167,123.
(b)
The rate shown is the annualized 7-day yield.
(c)
Security purchased with cash collateral received for securities on loan.
GDR —
Global Depositary Receipt

The following is a summary of the inputs used to value the fund’s investments as of January 31, 2024 (see notes to portfolio holdings for additional information):
DESCRIPTION
QUOTED PRICES IN
ACTIVE MARKETS FOR
IDENTICAL ASSETS
(LEVEL 1)
OTHER SIGNIFICANT
OBSERVABLE INPUTS
(LEVEL 2)
SIGNIFICANT
UNOBSERVABLE INPUTS
(LEVEL 3)
TOTAL
Assets
Common Stocks1
$
$472,382,955
$
$472,382,955
Brazil
1,297,922
1,297,922
Canada
11,376,511
11,376,511
Israel
1,843,588
1,843,588
United Kingdom
5,976,403
73,942,923
79,919,326
Short-Term Investments1
3,904,501
3,904,501
Total
$24,398,925
$546,325,878
$—
$570,724,803
1
As categorized in the Portfolio Holdings.
16  

Schwab Active Equity Funds
Notes to Portfolio Holdings (Unaudited)
Pursuant to Rule 2a-5 under the Investment Company Act of 1940, as amended (the 1940 Act), the Board of Trustees (the Board) has designated authority to a Valuation Designee, the funds’ investment adviser, to make fair valuation determinations under adopted procedures, subject to Board oversight. The investment adviser has formed a Pricing Committee to administer the pricing and valuation of portfolio securities and other assets and liabilities as well as to ensure that prices used for internal purposes or provided by third parties reasonably reflect fair value. The Valuation Designee may utilize independent pricing services, quotations from securities and financial instrument dealers and other market sources to determine fair value.
Securities held in the funds’ portfolio are valued every business day. The following valuation policies and procedures are used by the Valuation Designee to value various types of securities:
• Securities traded on an exchange or over-the-counter: Traded securities are valued at the closing value for the day, or, on days when no closing value has been reported, at the mean of the most recent bid and ask quotes. Securities that are primarily traded on foreign exchanges are valued at the official closing price or the last sales price on the exchange where the securities are principally traded with these values then translated into U.S. dollars at the current exchange rate, unless these securities are fair valued as discussed below.
• Foreign equity security fair valuation: The Valuation Designee has adopted procedures to fair value foreign equity securities that are traded in markets that close prior to the valuation of a fund’s holdings. By fair valuing securities whose prices may have been affected by events occurring after the close of trading, the Valuation Designee seeks to establish prices that investors might expect to realize upon the current sales of these securities. This methodology is designed to deter “arbitrage” market timers, who seek to exploit delays between the change in the value of a fund’s portfolio holdings and the net asset value (NAV) of a fund’s shares and seeks to help ensure that the prices at which a fund’s shares are purchased and redeemed are fair and do not result in dilution of shareholder interest or other harm to shareholders. When fair value pricing is used at the open or close of a reporting period, it may cause a temporary divergence between the return of a fund and that of its comparative index or benchmark.
• Futures contracts: Futures contracts are valued at their settlement prices as of the close of their exchanges.
• Mutual funds: Mutual funds are valued at their respective NAVs.
• Securities for which no quoted value is available: The Valuation Designee has adopted procedures to fair value a fund’s securities when market prices are not “readily available” or are unreliable. For example, a security may be fair valued when it’s de-listed or its trading is halted or suspended; when a security’s primary pricing source is unable or unwilling to provide a price; or when a security’s primary trading market is closed during regular market hours. Fair value determinations are made in good faith in accordance with adopted valuation procedures. The Valuation Designee considers a number of factors, including unobservable market inputs, when arriving at fair value. The Valuation Designee may employ methods such as the review of related or comparable assets or liabilities, related market activities, recent transactions, market multiples, book values, transactional back-testing, disposition analysis and other relevant information. Due to the subjective and variable nature of fair value pricing, there can be no assurance that a fund could obtain the fair value assigned to the security upon the sale of such security.
In accordance with the authoritative guidance on fair value measurements and disclosures under generally accepted accounting principles in the United States of America (GAAP), the funds disclose the fair value of their investments in a hierarchy that prioritizes the significant inputs to valuation methods used to measure the fair value. The hierarchy gives the highest priority to valuations based upon unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to valuations based upon unobservable inputs that are significant to the valuation (Level 3 measurements). If inputs used to measure the financial instruments fall within different levels of the hierarchy, the categorization is based on the lowest level input that is significant to the valuation. If it is determined that either the volume and/or level of activity for an asset or liability has significantly decreased (from normal conditions for that asset or liability) or price quotations or observable inputs are not associated with orderly transactions, increased analysis and the Valuation Designee’s judgment will be required to estimate fair value.
The three levels of the fair value hierarchy are as follows:
• Level 1 — quoted prices in active markets for identical investments — Investments whose values are based on quoted market prices in active markets. These generally include active listed equities, mutual funds, exchange-traded funds (ETFs) and futures contracts. Mutual funds and ETFs are classified as Level 1 prices, without consideration to the classification level of the underlying securities held which could be Level 1, Level 2 or Level 3 in the fair value hierarchy.
• Level 2 — other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.) — Investments that trade in markets that are not considered to be active, but whose values are based on quoted market prices, dealer quotations or valuations provided by alternative pricing sources supported by observable inputs are classified as Level 2 prices. These generally include U.S. government and sovereign obligations, most government agency securities, investment-grade corporate bonds, certain mortgage products, less liquid listed equities, and state, municipal and provincial obligations. In addition, international securities whose markets close hours before the valuation of a fund’s holdings
  17

Schwab Active Equity Funds
Notes to Portfolio Holdings (Unaudited) (continued)
may require fair valuations due to significant movement in the U.S. markets occurring after the daily close of foreign markets. The Valuation Designee has approved a vendor that calculates fair valuations of international equity securities based on a number of factors that appear to correlate to the movements in the U.S. markets.
• Level 3 — significant unobservable inputs (including the Valuation Designee’s assumptions in determining the fair value of investments) — Investments whose values are classified as Level 3 prices have significant unobservable inputs, as they may trade infrequently or not at all. When observable prices are not readily available for these securities, one or more valuation methods are used for which sufficient and reliable data is available. The inputs used in estimating the value of Level 3 prices may include the original transaction price, quoted prices for similar securities or assets in active markets, completed or pending third-party transactions in the underlying investment or comparable issuers, and changes in financial ratios or cash flows. Level 3 prices may also be adjusted to reflect illiquidity and/or non-transferability, with the amount of such discount estimated in the absence of market information. Assumptions used due to the lack of observable inputs may significantly impact the resulting fair value and therefore a fund’s results of operations.
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
The levels associated with valuing the fund’s investments as of January 31, 2024, are disclosed in the fund’s Portfolio Holdings.
REG87636JAN24
18